• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Marilyn Tavenner: Affordability the Biggest Challenge Facing Insurers

Video

According to Marilyn Tavenner, president and CEO of America’s Health Insurance Plans, consumer and provider education plays a large role in the healthcare system’s transition to alternative payment-models and value-based care. Affordability is the operative word, for which Tavenner expects to be insurers biggest challenge in the coming future.

Consumer and provider education plays a large role in the healthcare system’s transition to alternative payment models and value-based care, explained Marilyn Tavenner, president and CEO of America’s Health Insurance Plans (AHIP). Affordability is the operative word, for which Tavenner expects to be insurers biggest challenge in the coming future.

Transcript (slightly modified):

What are the concerns AHIP’s members have voiced as the US healthcare system moves toward alternative payment-models and value-based care?

I think the biggest concerns are, our members are very enthusiastic about moving to this model and our members have much more experience with capitation, are paying for an episode of bundle of care, but providers do not have as much experience. So the concern is making sure that providers are educated, they have the technology they need, the consumers understand where we’re going and they’re on board.

So I think it’s really a big education process for consumers and for providers but it’s also making sure we move in a steady path and we don’t try to go there all at once and confuse people or have unintended consequences by moving too rapidly when people aren’t ready to go.

What do you think is the biggest challenge facing insurers in the next year?

Affordability, affordability, affordability. That’s going to be something you hear about. You’ll hear about it from Congress, you’ll hear about it from both presidential candidates, and you’ll hear about it from us. Pharma’s obviously a big piece of that but it’s not just pharma. It’s general services. How do we go about getting cost in line with what our economy and the public can handle? It’s a number 1 issue for consumers, understandably so.

Related Videos
Dr Marco del Riccio
Michael David Chuong, MD, radiation oncologist, Miami Cancer Institute, Baptist Health South Florida
Yuman Fong, MD, cancer surgeon, City of Hope
Dr Marco del Riccio
Elena Elimova, MD, associate professor in the Department of Medicine at the University of Toronto and staff medical oncologist at Princess Margaret Hospital
Dr Eric Yang
Adam Brufsky, MD, PhD, University of Pittsburgh
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
Dr Marco Del Riccio
© 2026 MJH Life Sciences
AJMC®
All rights reserved.